AMERICAN CENTURY COMPANIES INC – Regeneron Pharmaceuticals, Inc. Transaction History
AMERICAN CENTURY COMPANIES INC portfolio value:
$811.53M
portfolio value
AMERICAN CENTURY COMPANIES INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.11% | 1.34K shares | 115.93M | $688.87 | 1.17M |
| Q2 2022 | share | Increase | +6.75% | 74.42K shares | -74.27M | $591.13 | 1.17M |
| Q1 2022 | share | Increase | +3.51% | 37.37K shares | 97.34M | $698.42 | 1.10M |
| Q4 2021 | share | Decrease | -9.34% | -109.72K shares | -38.35M | $642.51 | 1.06M |
| Q3 2021 | share | Increase | +1.70% | 19.59K shares | 65.72M | $605.18 | 1.17M |
| Q2 2021 | share | Increase | +4.55% | 50.31K shares | 122.44M | $558.54 | 1.15M |
| Q1 2021 | share | Increase | +19.30% | 178.72K shares | 75.32M | $473.14 | 1.10M |
| Q4 2020 | share | Decrease | -0.41% | -3.76K shares | -73.10M | $483.11 | 926.03K |
| Q3 2020 | share | Increase | +3.49% | 31.33K shares | -39.84M | $559.78 | 929.80K |
| Q2 2020 | share | Decrease | -7.64% | -74.29K shares | 85.34M | $623.65 | 898.47K |
| Q1 2020 | share | Decrease | -3.63% | -36.67K shares | 95.96M | $488.29 | 972.76K |
| Q4 2019 | share | Increase | +6.94% | 65.51K shares | 117.18M | $375.48 | 1.00M |
| Q3 2019 | share | Decrease | -8.54% | -88.09K shares | -61.17M | $277.4 | 943.92K |
| Q2 2019 | share | Decrease | -0.87% | -9.03K shares | -104.45M | $313 | 1.03M |
| Q1 2019 | share | Increase | +3.74% | 37.57K shares | 52.67M | $410.62 | 1.04M |
| Q4 2018 | share | Increase | +16.59% | 142.77K shares | 27.04M | $373.5 | 1.00M |
| Q3 2018 | share | Decrease | -5.64% | -51.43K shares | 33.07M | $404.04 | 860.69K |
| Q2 2018 | share | Decrease | -4.71% | -45.06K shares | -14.94M | $344.99 | 912.12K |
| Q1 2018 | share | Increase | +9.07% | 79.60K shares | -320K | $344.36 | 957.18K |
| Q4 2017 | share | Decrease | -4.36% | -39.96K shares | -80.31M | $375.96 | 877.58K |
| Q3 2017 | share | Increase | +2.25% | 20.21K shares | -30.46M | $447.12 | 917.55K |
| Q2 2017 | share | Increase | +5.79% | 49.14K shares | 112.03M | $491.14 | 897.33K |
| Q1 2017 | share | Increase | +25.19% | 170.69K shares | 79.98M | $387.51 | 848.19K |
| Q4 2016 | share | Increase | +1.65% | 10.98K shares | -19.24M | $367.09 | 677.49K |
| Q3 2016 | share | Increase | +10.69% | 64.34K shares | 57.65M | $402.02 | 666.51K |
| Q2 2016 | share | Increase | +19.05% | 96.34K shares | 27.97M | $349.23 | 602.16K |
| Q1 2016 | share | Increase | +1.80% | 8.94K shares | -87.42M | $360.44 | 505.82K |